Lynne Rosenblum

Title: Lynne Rosenblum: Innovator in Cystic Fibrosis Research

Introduction

Lynne Rosenblum is a prominent inventor based in Hopkinton, MA (US). She has made significant contributions to the field of genetics, particularly in the diagnosis of cystic fibrosis. With a total of five patents to her name, her work has had a profound impact on medical diagnostics.

Latest Patents

Among her latest patents is a groundbreaking invention related to mutations associated with cystic fibrosis. This invention provides novel mutations identified in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. These mutations can be utilized for a more accurate diagnosis of cystic fibrosis (CF) and CF-related disorders. The methods outlined in her patent involve testing a sample obtained from a subject to determine the presence of one or more mutations in the CFTR gene. The presence of these mutations indicates that the subject has CF, a CF-related disorder, or is a carrier of a CFTR mutation.

Career Highlights

Lynne Rosenblum is currently employed at Laboratory Corporation of America Holdings, where she continues her research and development efforts. Her work is instrumental in advancing the understanding and diagnosis of genetic disorders.

Collaborations

Lynne collaborates with several talented individuals in her field, including Elizabeth Rohlfs and Deborah Alexa Sirko-Osadsa. These collaborations enhance the research efforts and contribute to the innovative solutions being developed.

Conclusion

Lynne Rosenblum's contributions to cystic fibrosis research exemplify her dedication to improving medical diagnostics. Her innovative patents and collaborative efforts continue to pave the way for advancements in genetic testing and treatment.